Key facts
- It has raised $590K; the latest was Early Stage VC ($590K) in Feb 2026.
- Notable investors include Angels Capital, Dacsa Group, Enisa National Innovation Company, Hortensia Roig, Julia Barroso — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Biotasmart
- ·The full record, as it builds
Funding rounds
No funding rounds for Biotasmart are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biotasmart
Developer of a microbiota analysis platform intended to support personalized health and nutrition optimization. The company offers at-home intestinal microbiota testing and bacterial analysis software with personalized nutritional recommendations, enabling individuals and healthcare professionals to obtain microbiome insights and tailored nutrition guidance to improve digestive health, metabolic health, and overall well-being.
- Sector
- Healthcare
- HQ
- Valencia, Spain
- Founded
- 2024
- Website
- biotasmart.com/
- Ownership
- Privately Held (backing)
Biotasmart doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biotasmart shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biotasmart in its N-PORT filings yet. We sweep new filings monthly.